Sustainability initiatives are often viewed as long-term investments that require higher upfront costs before operational savings are realized. However, Bayer’s Cell Therapy Launch Facility in Berkeley, California, is demonstrating that sustainable facility design can generate significant financial and operational benefits from the outset. The facility, which became operational in 2023, earned 2025 ISPE Facility of the Year Award (FOYA) recognition in the Social Impact – Unmet Medical Needs category and achieved LEED v4 Platinum certification, the highest level awarded by the U.S. Green Building Council.
The facility’s sustainability journey and the lessons learned during its development are expected to be highlighted at the 2026 ISPE Annual Meeting & Expo, where Regina Donaldson, site sustainability lead and site energy manager at Bayer, will discuss how sustainability goals were successfully integrated into a GMP-regulated manufacturing environment without compromising compliance or increasing costs.
According to Donaldson, Bayer selected the LEED v4 framework because of its global recognition and applicability across a wide range of facility types and project phases. In addition to promoting energy efficiency, the framework encourages transparency around building materials, lifecycle assessments, energy metering, water usage, waste reduction, and occupant well-being. Bayer viewed the certification process as an opportunity to advance its broader sustainability goals while creating a facility capable of producing advanced cell therapies in an environmentally responsible manner.
The project initially targeted LEED Gold certification, but as design and construction progressed, the project team recognized that Platinum certification was achievable with only a limited number of additional enhancements. This realization prompted the organization to pursue the highest certification tier, ultimately demonstrating that ambitious sustainability targets could be reached without substantial increases in project complexity or cost.
One of the key themes of the project was the integration of sustainability considerations throughout both facility design and future operations. Donaldson notes that LEED requirements extend beyond traditional construction elements and require organizations to evaluate the entire lifecycle of a building. This included consideration of operational efficiency, material selection, energy consumption, and manufacturing flexibility. For a GMP-regulated facility, balancing these objectives with quality and compliance requirements required extensive collaboration among engineering, construction, utility, and operational teams.
Importantly, Bayer found that GMP requirements did not prevent the organization from pursuing LEED credits. Rather than abandoning sustainability initiatives due to regulatory constraints, the project team incorporated GMP requirements into the design process and sought opportunities to maximize sustainability performance elsewhere. Technologies and equipment were evaluated to ensure they met user requirements and compliance expectations while still contributing to environmental goals.
The greatest sustainability gains came from the facility’s energy strategy. The team focused on implementing technologies that minimized energy consumption while maintaining operational performance. These initiatives included using 100 percent LED lighting, installing rooftop solar panels, and utilizing an electric steam boiler instead of connecting to a natural gas-powered central steam generation system. However, the project’s most impactful innovation was the installation of four-pipe heat pump technology, making the Berkeley facility one of the first within Bayer and among the earliest facilities in the western United States to deploy the technology on this scale.
The heat pump system proved especially significant because it challenged the assumption that sustainable technologies necessarily increase project costs. During project planning, Bayer compared the heat pump solution with a conventional connection to centralized utility systems. The analysis showed that the heat pump approach would reduce construction time by approximately 16 weeks and lower utility installation costs by roughly US$5 million, cutting utility infrastructure expenses in half. These savings were realized immediately rather than years after the facility became operational.
Additional benefits have continued to accrue since startup. By avoiding reliance on traditional natural gas-powered steam generation and reducing dependence on centralized chilled water systems, the facility has lowered carbon emissions, reduced water consumption, and minimized future maintenance requirements. Because the heat pump system contains fewer components than many conventional alternatives, Bayer also anticipates lower long-term maintenance costs and increased operational efficiency.
The facility’s overall energy performance further reinforced the value of its sustainability strategy. Design decisions implemented during construction contributed to a reported 52.6 percent reduction in energy costs, enabling the project to earn the maximum available LEED points for optimized energy efficiency. According to Donaldson, these improvements represented a strategic, low-risk decision that delivered both environmental and economic benefits.
Beyond Bayer’s specific project, Donaldson believes many of the lessons learned can be applied by organizations that are not pursuing formal LEED certification. She encourages manufacturers to first define the sustainability outcomes they hope to achieve and then identify practical technologies that are impactful, cost-effective, and easy to maintain. Leveraging established sustainability frameworks, collaborating with industry peers, and adopting proven high-efficiency technologies can help organizations make meaningful progress without necessarily embarking on a formal certification journey.
As sustainability becomes an increasingly important priority across the pharmaceutical and biotechnology industries, Bayer’s Berkeley facility provides a compelling example of how environmental stewardship and operational efficiency can work together. The facility’s recognition in last year's ISPE FOYA program, coupled with its forthcoming spotlight at the 2026 ISPE Annual Meeting & Expo, highlights how strategic facility design can simultaneously support compliance, reduce environmental impact, and deliver measurable business value from day one.
Learn More About the 2026 ISPE Annual Meeting & Expo
Bioprocess Online, part of the Life Science Connect network, provides biopharmaceutical professionals with expert insights on biologics manufacturing, process development, facility design, automation, quality, validation, and sustainability. The publication delivers technical articles, industry news, case studies, and thought leadership focused on advancing innovation and operational excellence across the bioprocessing and biomanufacturing industries.